Why ViziLite Plus Is Important

Why ViziLite Plus is Important 

Early Detection is Critical

Your patients rely on you to be an expert in oral health. Dentists and hygenists are the best overall defense against oral cancer -- you are, in fact, a lifesaver. No other medical professionals are as well positioned to address this potentially deadly disease at its earliest stage. The key is to identify oral abnormalities at their most easily treated stage of development.

Fortunately, there's a simple technology to help in your fight against oral cancer. ViziLite Plus aids in the early identification of oral abnormalities that can lead to cancer. Cleared by the FDA, ViziLite Plus allows dentists to offer superior care to patients. Annual ViziLite Plus exams can be integrated with exsisting patient services, improving patient care and creating a positive financial impact in dental practices.

ViziLite Plus Oral Screening Protocol

ViziLite Plus should be offered annually to all new and re-care adult patients following the standard head and neck exam. Patients with a history of oral cancer should receive at least semi-annual ViziLite Plus exams.

As is the case with most cancers, age is the primary risk factor for oral cancer. Approximately 90% of oral cancer victims are age 40 and older, recent studies indicate that increasingly, patients younger than age 40 are being diagnosed with oral cancer. Though tobacco and alcohol use are the primary lifestyle risk factors that contribute to the development of oral cancer, 27% of oral cancer victims do not use tobacco or alcohol, and have no lifestyle risk factors. Oral cancer affects men more than women, 2:1, but oral cancer in women is on the rise nationwide.


Fact: 27% of oral cancers occur in people who don’t smoke and have no other risk factors.

Increased risk

  • Patients age 18-39

High risk

  • Patients age 40 and older
  • Tobacco users (any type, any age, within 10 years)

Highest risk 

  • Patients age 40 and older with lifestyle risk factors          
    (Tobacco, alcohol, HPV)
  • Patients with history of oral cancer